Quarrels have broken out behind the scenes of Anthem’s proposed acquisition of Cigna, as the health insurers seek regulatory approval for their landmark deal, the Wall Street Journal reported on Sunday.
The newspaper said the squabbles could delay or derail antitrust approvals, though the deal does not appear to be in danger of imminent collapse.
An Anthem spokeswoman declined to comment on the Journal report. Cigna officials were not immediately available to comment.
In a series of letters between top officials including their chief executives, the Journal said Anthem and Cigna accuse each other of violating the July merger agreement and fumbling submissions to regulators.
A key point of contention is Anthem’s lawsuit against Express Scripts Holding Co, a middleman for prescription drugs, according to the newspaper. The suit accuses Express Scripts of overcharging Anthem for drugs.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
K&L Gates Expands Antitrust Practice with New Partners
May 15, 2024 by
CPI
Polish Regulators Probe PS Store and Steam for Antitrust Violations
May 15, 2024 by
CPI
French Regulator Meat-Cutting Sector Case Following Antitrust Review
May 15, 2024 by
CPI
Arizona Attorney General Files Suit Against Amazon Over Unfair Business Practices
May 15, 2024 by
CPI
Varsity Spirit and Private Equity Owners Settle Class Action Antitrust Suit
May 15, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI